Trials / Completed
CompletedNCT02447614
Follow-up Studies of Primary Snoring(PS) and Obstructive Sleep Apnea Hypopnea Syndrome(OSAHS) in Chinese Children
Follow-up Studies of PS and OSAHS in Chinese Children
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- Beijing Children's Hospital · Academic / Other
- Sex
- All
- Age
- 3 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to investigate the natural course of Primary snoring in 1-2 years or more and the different effect of drug and surgical treatment applied in children with obstructive sleep apnea (OSAS) by comparing the polysomnography(PSG) and sleep questionaires in 6 months after treatment.
Detailed description
The evolution of snoring and OSAS in children is not well established since few studies have been published.This study is designed to evaluate the evolution of primary snoring and OSAS in children who had been submitted to watchful waiting 、drug or adenotonsillectomy.The participated children will be evaluated by full physical examination and nocturnal polysomnography(PSG), after which they were divided into 2 groups: apnea and snoring. After 6 months following the initial evaluation, patients were submitted to a new nocturnal polysomnography, and all data were compared to those of the first examination.And after 3 months and 12 months following the initial evaluation, patients will be called to complete the sleep questionnaire.Then analyse the change of parameters of polysomnography after 6 months of follow-up,and describe the changes of items of sleep questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Adenotonsillectomy | Adenotonsillectomy |
| OTHER | Conservative treatment | Mometasone Furoate Aqueous Nasal Spray or uticasone propionate (1/once qd) and(or)Leukotriene antagonists(4 or 5mg/once qn) or H1 receptor antagonists |
| OTHER | no treatment | just regular follow-up |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2022-06-01
- Completion
- 2022-07-01
- First posted
- 2015-05-19
- Last updated
- 2022-07-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02447614. Inclusion in this directory is not an endorsement.